http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103012192-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2332ae20dac0b583dd5c82e569adef54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
filingDate 2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2672330b78883ac1fe0f1efd811d2fef
publicationDate 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103012192-B
titleOfInvention Novel aceglutamide compound and pharmaceutical composition thereof
abstract The invention discloses a novel aceglutamide compound. The purity of the compound is greater than 99.6%. At the same time, the invention further discloses a pharmaceutical composition of the novel aceglutamide compound. The composition comprises the following components in parts by weight: 90-600 parts of aceglutamide, 6-40 parts of alliin, 1-8 parts of mannitol, 0.8-5 parts of disodium hydrogen phosphate and 0.5-3 parts of sodium dihydrogen phosphate. In the pharmaceutical composition of the novel aceglutamide compound disclosed by the invention, the synergistic effect is generated among the mannitol, the disodium hydrogen phosphate and the sodium dihydrogen phosphate, so that the stability of the composition under high temperature, high humidity and bright light is enhanced; and the aceglutamide and the alliin mutually take synergistic effect and can play a role of observably reducing blood ammonia.
priorityDate 2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID182230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92256142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447574277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829

Total number of triples: 38.